Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
Aimei Health Technology terminated its Business Combination Agreement with United Hydrogen Group Inc. after the transaction failed to close by the applicable outside date.
The termination was effective July 7, 2026, pursuant to Section 9.1(b) of the agreement originally signed in June 2024.
CEO Xie Junheng stated the company remains confident in finding a new target while thanking the United Hydrogen team for their efforts.